Zu "GeneID 931" wurden 420 Artikel gefunden!
Für die Filterung wurden keine Ergebnisse gefunden!
Rituximab
Artikelnummer: TGM-T9910-10mg
Description: Rituximab (anti-CD20) is a chimeric anti-CD20 mAb that binds the CD20 antigen on B cells with a binding affinity of 5 nM. Target: Others. References: Du J, et al. Structural basis for recognition of CD20 by therapeutic antibody Rituximab. J Biol Chem. 2007 May 18,282(20).
| MW: | 148 kD |
ab 224,00 €
Obinutuzumab
Artikelnummer: TGM-T9924-1mg
Description: Obinutuzumab (Obinutuzumab/afutuzumab) GA101) is a glycoengineered Type II CD20 monoclonal antibody in development for non-Hodgkin lymphoma. Target: Others. References: Herter S, et al. Preclinical activity of the type II CD20 antibody GA101 (obinutuzumab) compared with rituximab and ofatumumab in vitro...
| Schlagworte: | Obinutuzumab/afutuzumab |
| MW: | 150 kD |
ab 241,00 €
CD20 Protein, Human, Recombinant (His & Avi)
Artikelnummer: TGM-TMPK-00183-100ug
Description: B-lymphocyte antigen CD20 or CD20 is an activated-glycosylated phosphoprotein expressed on the surface of all B-cells beginning at the pro-B phase (CD45R , CD117) and progressively increasing in concentration until maturity.CD20 is the target of the monoclonal antibodies rituximab, ocrelizumab,...
| Schlagworte: | S7, B1, CD20S7, CD20, CD20 receptor, CVID5, MS4A-1, Ly-44, MS4A2, MS4A1, Bp35, LEU-16 |
| MW: | 16.8 kD |
ab 455,00 €
CD20 Protein, Human, Recombinant (His & Avi), Biotinylated
Artikelnummer: TGM-TMPK-00184-100ug
Description: B-lymphocyte antigen CD20 or CD20 is an activated-glycosylated phosphoprotein expressed on the surface of all B-cells beginning at the pro-B phase (CD45R , CD117) and progressively increasing in concentration until maturity.CD20 is the target of the monoclonal antibodies rituximab, ocrelizumab,...
| Schlagworte: | MS4A-1, CD20, B-lymphocyte surface antigen B1, Leukocyte surface antigen Leu-16, Membrane-spanning 4-domains subfamily A... |
| MW: | 16.8 kD |
ab 798,00 €
CD20 Protein, Human, Recombinant (Flag)
Artikelnummer: TGM-TMPJ-00184-10ug
Description: CD20 Protein, Human, Recombinant (Flag) is expressed in HEK293 mammalian cells with C-Flag tag. The predicted molecular weight is 33-37 kDa and the accession number is P11836.
| Schlagworte: | MS4A1, Leukocyte surface antigen Leu-16, CD20, Bp35, B-lymphocyte surface antigen B1, Membrane-spanning 4-domains... |
| MW: | 37 kD |
ab 455,00 €
CD20 Protein, Human, Recombinant (His & Flag)
Artikelnummer: TGM-TMPJ-00185-10ug
Description: CD20 Protein, Human, Recombinant (His & Flag) is expressed in HEK293 mammalian cells with C-6xHis-Flag tag. The predicted molecular weight is 34-40 kDa and the accession number is P11836.
| Schlagworte: | Membrane-spanning 4-domains subfamily A member 1, CD20, Leukocyte surface antigen Leu-16, B-lymphocyte surface antigen B1,... |
| MW: | 40 kD |
ab 363,00 €
B-lymphocyte antigen CD20 (MS4A1), human, recombinant
Artikelnummer: CSB-CF015007HU.100
Organism: Homo sapiens (Human). Source: in vitro E.coli expression system. Expression Region: 1-297aa. Protein Length: Full Length. Tag Info: N-terminal 10xHis-tagged. Target Protein Sequence: MTTPRNSVNG TFPAEPMKGP IAMQSGPKPL FRRMSSLVGP TQSFFMRESK TLGAVQIMNG LFHIALGGLL MIPAGIYAPI CVTVWYPLWG GIMYIISGSL LAATEKNSRK...
| Schlagworte: | Bp35, CD20, MS4A1, B-lymphocyte antigen CD20, B-lymphocyte surface antigen B1, Leukocyte surface antigen Leu-16,... |
| Anwendung: | Activity not tested |
| Exprimiert in: | E.coli in vitro |
| Ursprungsart: | human |
| MW: | 34.6 kD |
ab 914,00 €
B-lymphocyte antigen CD20 (MS4A1), partial, human,...
Artikelnummer: CSB-EP015007HU2.1
Organism: Homo sapiens (Human). Source: E.coli. Expression Region: 209-297aa. Protein Length: Partial. Tag Info: N-terminal GST-tagged. Target Protein Sequence: AGIVENEWKR TCSRPKSNIV LLSAEEKKEQ TIEIKEEVVG LTETSSQPKN EEDIEIIPIQ EEEEEETETN FPEPPQDQES SPIENDSSP. Purity: Greater than 85% as determined by SDS-PAGE....
| Schlagworte: | Bp35, CD20, MS4A1, B-lymphocyte antigen CD20, B-lymphocyte surface antigen B1, Leukocyte surface antigen Leu-16,... |
| Anwendung: | Activity not tested |
| Exprimiert in: | E.coli |
| Ursprungsart: | human |
| MW: | 36.9 kD |
ab 213,00 €
B-lymphocyte antigen CD20 (MS4A1), partial, human,...
Artikelnummer: CSB-YP015007HU1.1
Organism: Homo sapiens (Human). Source: Yeast. Expression Region: 141-297aa. Protein Length: Partial. Tag Info: N-terminal 6xHis-tagged. Target Protein Sequence: IKISHFLKME SLNFIRAHTP YINIYNCEPA NPSEKNSPST QYCYSIQSLF LGILSVMLIF AFFQELVIAG IVENEWKRTC SRPKSNIVLL SAEEKKEQTI EIKEEVVGLT ETSSQPKNEE DIEIIPIQEE EEEETETNFP...
| Schlagworte: | Bp35, CD20, MS4A1, B-lymphocyte antigen CD20, B-lymphocyte surface antigen B1, Leukocyte surface antigen Leu-16,... |
| Anwendung: | Activity not tested |
| Exprimiert in: | Yeast |
| Ursprungsart: | human |
| MW: | 20 kD |
ab 235,00 €
B-lymphocyte antigen CD20 (MS4A1)-VLPs (Active), human,...
Artikelnummer: CSB-MP015007HU.1
Organism: Homo sapiens (Human). Source: Mammalian cell. Expression Region: 1-297aa. Protein Length: Full Length. Tag Info: C-terminal 10xHis-tagged (This tag can be tested only under denaturing conditions). Target Protein Sequence: MTTPRNSVNG TFPAEPMKGP IAMQSGPKPL FRRMSSLVGP TQSFFMRESK TLGAVQIMNG LFHIALGGLL...
| Schlagworte: | Bp35, CD20, MS4A1, B-lymphocyte antigen CD20, B-lymphocyte surface antigen B1, Leukocyte surface antigen Leu-16,... |
| Anwendung: | Active protein |
| Exprimiert in: | Mammalian cells |
| Ursprungsart: | human |
| MW: | 34.4 kD |
ab 510,00 €
Human CD20 Protein, hFc Tag
Artikelnummer: DIM-PME100046.10
Recombinant Human CD20 protein with N-terminal human Fc. hFc(Glu99-Ala330) CD20(Lys142-Ser188), Protein function: B-lymphocyte-specific membrane protein that plays a role in the regulation of cellular calcium influx necessary for the development, differentiation, and activation of B-lymphocytes (PubMed:3925015,...
| Schlagworte: | B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7 |
| Exprimiert in: | Human cells |
| Ursprungsart: | human |
| MW: | 31.6 kD |
ab 109,00 €
CD20 (human) full length protein-MNP
Artikelnummer: DIM-FLP100026.100
Plasma membrane-coated nanoparticles (MNPs) have been used in various applications, including delivery of therapeutic agents and induction of immune responses et al. Unlike the conventional strategies, MNPs directly leverage intact and natural functions of cell membranes, and show high biocompatibility, specificity,...
| Schlagworte: | CD20, Bp35, MS4A1, B-lymphocyte antigen CD20, B-lymphocyte surface antigen B1, Leukocyte surface antigen Leu-16,... |
| Anwendung: | Full length transmembrane protein, high biocompatib., ELISA, screening, immunization, cell-based assays |
| Exprimiert in: | Human cells |
| Ursprungsart: | human |
| MW: | 33.1 kD |
ab 1.680,00 €